Copper toxicity in Alzheimer's disease: Cognitive loss from ingestion of inorganic copper

Journal of Trace Elements in Medicine and Biology

Volumn 26, Issue 2-3, 2012, Pages 89-92

  Brewer, George J ^a,b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Adeona Pharmaceuticals   (United States)

Author keywords

Alzheimer's disease; Cognition loss; Copper

Indexed keywords

APOLIPOPROTEIN E4; COPPER; DRINKING WATER; HOMOCYSTEINE; MINERAL; TRANSFERRIN; VITAMIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; DEVELOPED COUNTRY; DIET SUPPLEMENTATION; ENVIRONMENTAL FACTOR; EPIDEMIC; HAZARD RATIO; HEMOCHROMATOSIS; HUMAN; INGESTION; JAPAN; LIPID DIET; MILD COGNITIVE IMPAIRMENT; MORTALITY; NEUROFIBRILLARY TANGLE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; WATER SUPPLY; WILSON DISEASE;

ALZHEIMER DISEASE; COGNITION; COPPER; DIET, HIGH-FAT; HUMANS; RISK FACTORS;

ANIMALIA;

EID: 84862572573     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2012.04.019     Document Type: Article

References (26)

1. Brewer G.J. The risks of copper toxicity contributing to cognitive decline in the aging population and to Alzheimer's disease. J Am Coll Nutr 2009, 28:238-242.
2. Brewer G.J. Issues raised involving the copper hypotheses in the causation of Alzheimer's disease. Int J Alzheimers Dis 2011, 537528. 2011.
3. Alzheimer's Association. Alzheimer's Disease Facts and Figures 2010;1-74.
4. Waldman M., Lamb M. Dying for a hamburger: modern meat processing and the epidemic of Alzheimer's disease 2005, Thomas Dune Books/St. Martin's Press, New York. 1st U.S. ed.
5. Osler W. Modern medicine in theory and practice 1910, Lea and Febiger, Philadelphia and New York.
6. Gowers W.R. A manual of diseases of the nervous system 1888, P Blakiston, Son, and Co, Philadelphia.
7. Strachey J., Freud A., Strachey A., Tyson A. 24 volumes entitled, the standard edition of the complete psychological works of Sigmund Freud, written between 1895 and 1939 1966, The Hogarth Press and the Institute of Psycho-Analysis, London.
8. Boyd W. A textbook of pathology: an introduction to medicine 1938, Lea and Febiger, Philadelphia.
9. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005, 366:2112-2117.
10. Ueda K., Kawano H., Hasuo Y., Fujishima M. Prevalence and etiology of dementia in a Japanese community. Stroke 1992, 23:798-803.
11. White L., Petrovitch H., Ross G.W., Masaki K.H., Abbott R.D., Teng E.L., et al. Prevalence of dementia in older Japanese-American men in Hawaii: the Honolulu-Asia Aging Study. J Am Med Assoc 1996, 276:955-960.
12. Sparks D.L., Schreurs B.G. Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc Natl Acad Sci USA 2003, 100:11065-11069.
13. Sparks D.L., Friedland R., Petanceska S., Schreurs B.G., Shi J., Perry G., et al. Trace copper levels in the drinking water, but not zinc or aluminum, influence CNS Alzheimer-like pathology. J Nutr Health Aging 2006, 10:247-254.
14. Deane R., Sagare A., Coma M., Parisi M., Gelein R., Singh I., et al. A novel role for copper: disruption of LRP-dependent brain abeta clearence. Presentation at the annual meeting of the society for neuroscience 2007.
15. Hill G.M., Brewer G.J., Juni J.E., Prasad A.S., Dick R.D. Treatment of Wilson's disease with zinc. II. Validation of oral 64 copper with copper balance. Am J Med Sci 1986, 292:344-349.
16. Squitti R., Pasqualetti P., Dal Forno G., Moffa F., Cassetta E., Lupoi D., et al. Excess of serum copper not related to ceruloplasmin in Alzheimer disease. Neurology 2005, 64:1040-1046.
17. Squitti R., Barbati G., Rossi L., Ventriglia M., Dal Forno G., Cesaretti S., et al. Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau. Neurology 2006, 67:76-82.
18. Squitti R., Bressi F., Pasqualetti P., Bonomini C., Ghidoni R., Binetti G., et al. Longitudinal prognostic value of serum " free" copper in patients with Alzheimer disease. Neurology 2009, 72:50-55.
19. Morris M.C., Evans D.A., Tangney C.C., Bienias J.L., Schneider J.A., Wilson R.S., et al. Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Arch Neurol 2006, 63:1085-1088.
20. Mursu J., Robien K., Harnack L.J., Park K., Jacobs D.R. Dietary supplements and mortality rate in older women: the Iowa Women's Health Study. Arch Intern Med 2011, 171:1625-1633.
21. Miyata M., Smith J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 1996, 14:55-61.
22. Grant W.B. Dietary links to Alzheimer's disease. Alzheimers Dis Rev 1997, 2:42-55.
23. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New England J Med 2002, 346:476-483.
24. Moalem S., Percy M.E., Andrews D.F., Kruck T.P., Wong S., Dalton A.J., et al. Are hereditary hemochromatosis mutations involved in Alzheimer disease?. Am J Med Genet 2000, 93:58-66.
25. Zambenedetti P., De Bellis G., Biunno I., Musicco M., Zatta P. Transferrin C2 variant does confer a risk for Alzheimer's disease in caucasians. J Alzheimers Dis 2003, 5:423-427.
26. Bucossi S., Mariani S., Ventriglia M., Polimanti R., Gennarelli M., Bonvicini C., et al. Association between the c. 2495 A>G ATP7B polymorphism and sporadic Alzheimer's disease. Int J Alzheimers Dis 2011, (2011):973692.